Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 22, 2025 06:41 ET | Source: Research and Markets

Spinal Cord Stimulators Market Insights, Competitive Landscape, and Forecast Report 2024-2032: Rising Chronic Pain and Neuropathy Cases, Advancements in Rechargeable Devices, and Regional Growth

Dublin, Oct. 22, 2025 (GLOBE NEWSWIRE) -- The "Spinal Cord Stimulators - Market Insights, Competitive Landscape, and Market Forecast - 2032" has been added to ResearchAndMarkets.com's offering. ...
October 01, 2025 07:00 ET | Source: Comphya SA

Comphya Announces First Patient Implanted with CaverSTIM in U.S. Pilot Study at Johns Hopkins University School of Medicine

LAUSANNE, Switzerland, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Comphya SA, a clinical-stage MedTech company pioneering the first implantable neurostimulation therapy for erectile dysfunction (ED)...
September 24, 2025 08:18 ET | Source: Magstim EGI

EGI Launches Next-Generation HD-EEG Platform to Advance Understanding of Brain Function and Stimulation

EGI Launches Next-Generation HD-EEG Platform to Advance Understanding of Brain Function and Monitoring for Neuroscience Research-New GES 500
September 18, 2025 08:00 ET | Source: Curonix LLC

Curonix Expands the Freedom® PNS System Patient Treatment Options with the Launch of its Innovative Wearable Solution for Chronic Pain of the Head, Neck, Shoulder, and Torso

Curonix Expands the Freedom® PNS System Patient Treatment Options with the Launch of its Innovative Wearable Solution
September 16, 2025 10:18 ET | Source: ANEUVO

ANEUVO Showcases ExaStim® Therapy At RehaCare 2025 and ISCoS 2025

Los Angeles, CA, Sept. 16, 2025 (GLOBE NEWSWIRE) -- ANEUVO today announced its participation in two of the most influential international gatherings for spinal cord injury (SCI) rehabilitation and...
$European Refractory Epilepsy Treatment Market$

September 16, 2025 06:43 ET | Source: Research and Markets

Europe Refractory Epilepsy Treatment Research Report 2025 | Market to More Than Double to Reach $2.82 Billion by 2035, Driven by CBD Growth, Uptake of Neuromodulation Therapies, Strong R&D Pipeline

Dublin, Sept. 16, 2025 (GLOBE NEWSWIRE) -- The "Europe Refractory Epilepsy Treatment Market: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.The Europe...
$Asia-Pacific Refractory Epilepsy Treatment Market$

September 16, 2025 06:25 ET | Source: Research and Markets

Asia-Pacific Refractory Epilepsy Treatment Market Research 2025 | Market to Reach $2.48 Billion by 2035 - Opportunities Fueled by a Shift from Neo-Adjuvant Approaches Driven by Diagnostic Advancements

Dublin, Sept. 16, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Refractory Epilepsy Treatment Market: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.The...
September 05, 2025 08:00 ET | Source: electroCore, Inc.

electroCore Announces Departure of Peter Cuneo from the Board of Directors and Elects Thomas J. Errico, MD as Chairman of the Board

ROCKAWAY, N.J., Sept. 05, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the departure of Peter Cuneo from...
July 09, 2025 09:19 ET | Source: Magstim EGI

FDA Clears Updated Magstim Rapid Transcranial Magnetic Stimulation Research System

FDA has cleared the new Magstim Rapid TMS system for research and clinical applications, now with FDA clearance in the U.S. for the treatment of pain.
July 07, 2025 05:00 ET | Source: PathMaker Neurosystems Inc.

PathMaker Neurosystems Announces Publication of First Study Demonstrating Increased Survival in an ALS Mouse Model After Treatment With Non-Invasive Neuromodulation

PathMaker Announces Publication of First Study Demonstrating Increased Survival in an ALS Mouse Model After Treatment With Non-Invasive Neuromodulation